Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Zhongke Drug Research Institute is a high-tech pharmaceutical research organization based in Guangzhou, China, closely affiliated with the Chinese Academy of Sciences (CAS). The company specializes in the discovery and development of innovative small molecule therapeutics, particularly in the fields of oncology and metabolic disorders. It operates as both a proprietary drug developer and a contract research organization (CRO), providing services in medicinal chemistry, structural biology, and pharmacological evaluation. The institute leverages advanced structure-based drug design platforms to accelerate the transition of academic breakthroughs into clinical-stage candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Zhongke Pharmaceutical Research.